APA
Hernandez-Cueto A., Hernandez-Cueto D., Antonio-Andres G., Mendoza-Marin M., Jimenez-Gutierrez C., Sandoval-Mejia A. L., Mora-Campos R., Gonzalez-Bonilla C., Vega M. I., Bonavida B. & Huerta-Yepez S. (20150609). Death receptor 5 expression is inversely correlated with prostate cancer progression. : Molecular medicine reports.
Chicago
Hernandez-Cueto Angeles, Hernandez-Cueto Daniel, Antonio-Andres Gabriela, Mendoza-Marin Marisela, Jimenez-Gutierrez Carlos, Sandoval-Mejia Ana Lilia, Mora-Campos Rosario, Gonzalez-Bonilla Cesar, Vega Mario I, Bonavida Benjamin and Huerta-Yepez Sara. 20150609. Death receptor 5 expression is inversely correlated with prostate cancer progression. : Molecular medicine reports.
Harvard
Hernandez-Cueto A., Hernandez-Cueto D., Antonio-Andres G., Mendoza-Marin M., Jimenez-Gutierrez C., Sandoval-Mejia A. L., Mora-Campos R., Gonzalez-Bonilla C., Vega M. I., Bonavida B. and Huerta-Yepez S. (20150609). Death receptor 5 expression is inversely correlated with prostate cancer progression. : Molecular medicine reports.
MLA
Hernandez-Cueto Angeles, Hernandez-Cueto Daniel, Antonio-Andres Gabriela, Mendoza-Marin Marisela, Jimenez-Gutierrez Carlos, Sandoval-Mejia Ana Lilia, Mora-Campos Rosario, Gonzalez-Bonilla Cesar, Vega Mario I, Bonavida Benjamin and Huerta-Yepez Sara. Death receptor 5 expression is inversely correlated with prostate cancer progression. : Molecular medicine reports. 20150609.